Dapus Langlang Kurniawan

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 4

39

DAFTAR PUSTAKA

Aaronson I.P, Ward, T.P.J, 2010, The Cardiovascular System at a Glance, Alih
Bahasa:Surapsari,J.D, Jakarta: Penerbit Erlangga.

Aaronson, P.I., Ward, J.PT., Connolly, M.J., 2013. The Cardiovascular System
at a Glance 4th Edition, United Kingdom: Library of Congress
Cataloging, p. 101.

Addison, D, and Aguilar, D. 2011. Diabetes and Cardiovascular Disease: The


Potential Benefit of Incretin-Based Therapies. NIH Public Acces,
2011:13(2):115-112. doi:10,1007s1183-010-0153-0.

AHA, 2014. New statistical update looks at worldwide heart, stroke health:
American Heart Association Annual Statistical Update Report, AHA
(American Heart Association). http://newsroom.heart.org/news/new-
statistical-update-looks-at-worldwide-heart-stroke-health. diakses pada 4
april 2018

AHA, 2015. Types of Heart Failure, AHA (American Heart Association).


http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFa
ilure/Types-of-Heart-Failure_UCM_306323_Article.jsp#.VkoRZtKrTIV.
Diakses pada 4 april

AHA, 2015. Understand Your Risk of Heart Attack, AHA (American Heart
Association).http://www.heart.org/HEARTORG/Conditions/HeartAttack/
UnderstandYourRiskofHeartAttack/Understand-Your-Risk-of-Heart-
Attack_UCM_002040_Article.jsp#.Vh-UY-xViko. diakses pada 28 maret
2018

Anonim, 2014, Farmakope Indonesia Edisi V. Departemen Kesehatan Republik


Indonesia, Jakarta.

Anonim, 2015. Heart failure fact sheet. CDC (Center for dissease control and
prevention) Division for heart disease and stroke prevention,
http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/docs/fs_heart_failure
.pdf, diakses tanggal 14 Maret 2018.

Atherton JJ, Bauersachs J, Carerj S, Piotr Ponikowski, Adriaan A.Voors,Stefan


D.Anker, He ´ctor Bueno, John G. F. Cleland, Andrew J. S. Coats,
Volkmar Falk, Jose ´ Ramo ´nGonza ´lez-Juanatey, Veli-PekkaHarjola,
Ewa A. Jankowska, Mariell Jessup, Cecilia Linde, Petros
Nihoyannopoulos, John T. Parissis, Burkert Pieske, Jillian P. Riley,
Giuseppe M. C. Rosano, Luis M. Ruilope, Frank Ruschitzka, Frans H.
Rutten, Peter van der Meer (2016) 2016 ESC guidelines for the diagnosis
and treatment of acute and chronic heart failure. Eur Heart J
18(8):891–975.
Bui AL, Horwich TB, Fonarow GC. 2011. Epidemiology and risk profile of
heart failure. Nat Rev Cardiol. vol. 81 (pg. 30-41)
40

Chaggar PS, Shaw SM, Williams SG. 2015. Is foxglove effective in heart
failure? Cardiovasc Ther 33: 236-241 [PMID: 25925484DOI:
10.1111/1755-5922.12130]

Cotran and Robbins. 2015. Pathologic Basis of Disease Ed 9th, Canada: Book
Aid International. Hal. 531.

Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J.V., Ponikowski, P.,
Poole-Wilson, P.A., Stromberg, A., Veldhuisen, D.J.V., Atar, D., Hoes,
A.W., Keren, A., Mebazaa, A., Nieminem, M., Priori, S.G., Swedberg, K.,
2008. ESC Guidelines for The Diagnosis and Treatment of Acute and
Chronic Heart Failure. Eur J Heart Fail, p. 1-57.

Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G. & Posey, L.M.,
2011, Pharmacotherapy a Pathophysiologic Approach, eight Edition,
New york: Appleton and Lange

Francis, G. S., Bartos, J. A. & Adatya, S. 2014. Inotropes. J. Am. Coll. Cardiol.
63, 2069–2078.

Gaggin, H.K., Januzzi, J.L., 2015. Cardiac Biomarkers and Heart Failure.
American College of Cardiology.

Gunawan, Sulistia Gan. 2012. Farmakologi dan Terapi Edisi 5. Jakarta: Balai
Penerbit FKUI.

Hammer GD, McPhee SJ. Pathophysiology of disease: An introduction to clinical


medicine. 7 thed. New York: McGraw-Hill Education; 2014. Hal 255

Hardman, G. Joel., Limbird, E. Lee., 2014. Gilman, Goodman. Alferd (Eds).


Goodman and Gilmans Dasar Farmakologi Terapi. Edisi ke-10,
Jakarta: Buku Kedokteran EGC., hal 875.

Harvey, R.A., Pamela, C.C., 2013. Farmakologi Ulasan Bergambar,


Jakarta:EGC.

Isman Firdaus, dkk. PERHIMPUNAN DOKTER SPESIALIS


KARDIOVASKULAR INDONESIA 2016. Panduan praktik klinis (PPK)
dan clinical pathway penyakit jantung dan pembuluh darah (CP). Edisi
Pertama

Kakourus, N.S., Kakourus, S.N., 2015. Clinical Assesment in Acute Heart Failure.
Hellenic J Cardiol, p. 285-301.

Kasper, D.L., Fauci, A.S., Hauser, S.L., Longo, D.L., Jameson, J.L.J., Loscalzo,
J., 2015. Harrison’s: Principles of Internal Medicine. 19th Edition.
Uniter Stated: McGraw-Hill Education, pp.1503-1504.
41

Katzung, B.G., 2012. Farmakologi Dasar & Klinik: Basic & Clinical Pharmacology .
Edisi 10, Jakarta: Penerbit Buku Kedokteran EGC, hal 178-179, hal 203-204, hal
240-152.

Kementerian Kesehatan Republik Indonesia. Hasil Riset kesehatan dasar


http://www.depkes.go.id/resources/download/general/Hasil Riskesdas 2015 . Di
akses pada tgl 21 februari 2018.

Kemp, C.D., Conte, J.V., 2012. The Pathophysiology of Heart Failure.


Cardiovasc Pathol, Vol.21 No.5, p. 1-7.

Konstantinou DM, Karvounis H, Giannakoulas G. 2016. Digoxin in heart failure


with a reduced ejection fraction: a risk factor or a risk marker?
Cardiology.134(3):311–9.Stockley, I.H., Drug Interactions, University of
Nottingham Medical School, Nottingham, 1994.

Manurung, D., Muhadi., Gagal Jantung Akut. In: Sudoyo AW, Setiyohadi B, Alwi
I, Marcellus SK, Setiati S [Edt]. 2014. Buku Ajar Ilmu Penyakit Dalam
Jilid I. Edisi VI, Jakarta: Pusat Penerbitan Departemen Ilmu
Penyakit Dalam FKUI, p. 1136.

Marieb, E.N., Hoehn, K., 2013. Human Anatomy & Physiology 9th Edition, London:
Pearson Education, Inc.

Matti Kivikko, Piero Pollesello, Tuukka Tarvasmäki, Toni Sarapohja, Markku S.


Nieminen, Veli-Pekka Harjola. 2016. Effect of baseline characteristics on
mortality in the SURVIVE trial on the effect of levosimendan vs
dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
International Journal of Cardiology 215

Maury P, Rollin A, Galinier M, Juilliére Y. 2014. Role of digoxin in controlling


the ventricular rate during atrial fibrillation: a systematic review and
rethinking. Research Reports in Clinical Cardiology. 5: 93-101 [DOI:
10.2147/RRCC.S44919]

Neal, M.J. 2006. Medical Pharmacology At a Glance Edisi Kelima. Jakarta :


Penerbit Erlangga. Hal 43

Panggabean, M.M., Gagal Jantung. In: Sudoyo AW, Setiyohadi B, Alwi I,


Marcellus SK, Setiati S [Edt]. 2014. Buku Ajar Ilmu Penyakit Dalam
Jilid I. Edisi VI, Jakarta: Pusat Penerbitan Departemen Ilmu
Penyakit Dalam FKUI, p. 1132.

Price, S.A., Wilson, L.M., 2006. Patofisiologi : Konsep Klinis Proses-Proses


Penyakit. Edisi ke-6, Jakarta : Penerbit buku kedokteran EGC, hal 634-
636.

Rilantono, L.I., Baraas, F., Karo karo, S., Roebiono, P.S., 2001. Buku Ajar Kardiologi.
Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia, hal 120, hal
258-259
42

Ritter, J.M., Lewis, L.D., Mant, T.GK.,Ferro, A.,2008. A Textbook of Clinical


Pharmacology and Therapeutics. Fifth Edition. Hodden Education, part
of Hachette Livre UK, London

Roger VL. 2013. Epidemiology of heart failure. Circ Res. 113:646–59.

Shah, R.V., Fifer, M.A., 2007. Heart Failure. In: Lily LS [edt]. Pahophysiology
of Heart Disease. USA:Lippincott Williams & Wilkins.

Siswanto, B. Bambang., Hersunarti, Nani., Erinanto., Barack, Rosana., Praktikto,


S. Rarsari., Nauli, E. Siti., Lubis C. Anggia., 2015. Pedoman Tata
Laksana Gagal Jantung. Edisi ke-1, Jakarta:PERKI., hal 1-56.

Sweetman, S.C., 2009, Martindale The Complete Drug Reference, Thirty Sixth
Edition, Pharmaceutical Press, London • Chicago 1271-1272

Tacon Catherine L, John McCaffrey, Anthony Delaney. Dobutamine for patients


with severe heart failure: a systematic review and meta-analysis of
randomised controlled trials.
https://link.springer.com/content/pdf/10.1007%2Fs00134-011-2435-6 Di
akses pada tgl 21 februari 2018.
Tariq, S., Aronow, W.S., 2015. Use of Inotropic Agents in Treatment of Systolic
Heart Failure. Int J Mol Sci, p. 1-9.

Walker, Roger and Whittlesea, Cate. 2012. Clinical Pharmacy and Therapeutics.
Fifth edition 2012. Chuchil Livingstone, Elsevier.

Wells, B.G., Dipiro, J.T., Schwinghammer, T.L., and Dipiro, C.V., 2009.
Pharmacotherapy Handbook. Seventh Edition, The McGraw-Hill Companies,
Inc. All rights reserved, pp. 82-84.

Wells, B.G., DiPiro, J.T., Schwinghammer, T.L., DiPiro, C.V., 2015. Pharmacotherapy
Handbook 9th Edition, United States of America: McGraw-Hill Companies,
Inc, p. 75.

WHO, 2016. Cardiovascular diseases (CVDs), WHO (World Health Organization).


http://www.who.int/mediacentre/factsheets/fs317/en/. Diakses tanggal 15 maret
2018.

Zhang, X., Wang, W., Yu, Y., Wang, Q., Yang, Y., Wen, D., Li, F., Ouyang, N.,
Kan, L., Suo, M., Yan, H., 2013. BNP and NT-proBNP Assays for Heart-
Failure Diagnosis in Patients With Cerebral Infarction. Lab Medicine,
Vol.44 No.1, p. 1-5.

You might also like